Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer's disease

Alzheimer's disease (AD) can present with distinct clinical variants. Identifying the earliest neurodegenerative changes associated with each variant has implications for early diagnosis, and for understanding the mechanisms that underlie regional vulnerability and disease progression in AD. We...

Full description

Saved in:
Bibliographic Details
Published inHuman brain mapping Vol. 36; no. 11; pp. 4421 - 4437
Main Authors Ossenkoppele, Rik, Cohn-Sheehy, Brendan I., La Joie, Renaud, Vogel, Jacob W., Möller, Christiane, Lehmann, Manja, van Berckel, Bart N.M., Seeley, William W., Pijnenburg, Yolande A., Gorno-Tempini, Maria L., Kramer, Joel H., Barkhof, Frederik, Rosen, Howard J., van der Flier, Wiesje M., Jagust, William J., Miller, Bruce L., Scheltens, Philip, Rabinovici, Gil D.
Format Journal Article
LanguageEnglish
Published United States Blackwell Publishing Ltd 01.11.2015
John Wiley & Sons, Inc
John Wiley and Sons Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Alzheimer's disease (AD) can present with distinct clinical variants. Identifying the earliest neurodegenerative changes associated with each variant has implications for early diagnosis, and for understanding the mechanisms that underlie regional vulnerability and disease progression in AD. We performed voxel‐based morphometry to detect atrophy patterns in early clinical stages of four AD phenotypes: Posterior cortical atrophy (PCA, “visual variant,” n = 93), logopenic variant primary progressive aphasia (lvPPA, “language variant,” n = 74), and memory‐predominant AD categorized as early age‐of‐onset (EOAD, <65 years, n = 114) and late age‐of‐onset (LOAD, >65 years, n = 114). Patients with each syndrome were stratified based on: (1) degree of functional impairment, as measured by the clinical dementia rating (CDR) scale, and (2) overall extent of brain atrophy, as measured by a neuroimaging approach that sums the number of brain voxels showing significantly lower gray matter volume than cognitively normal controls (n = 80). Even at the earliest clinical stage (CDR = 0.5 or bottom quartile of overall atrophy), patients with each syndrome showed both common and variant‐specific atrophy. Common atrophy across variants was found in temporoparietal regions that comprise the posterior default mode network (DMN). Early syndrome‐specific atrophy mirrored functional brain networks underlying functions that are uniquely affected in each variant: Language network in lvPPA, posterior cingulate cortex‐hippocampal circuit in amnestic EOAD and LOAD, and visual networks in PCA. At more advanced stages, atrophy patterns largely converged across AD variants. These findings support a model in which neurodegeneration selectively targets both the DMN and syndrome‐specific vulnerable networks at the earliest clinical stages of AD. Hum Brain Mapp 36:4421–4437, 2015. © 2015 Wiley Periodicals, Inc.
Bibliography:State of California Department of Health Services Alzheimer's Disease Research Centre of California - No. 04-33516
Tau Consortium
istex:DECE2C4FDD0CD020B564C0775EEC22061BC76105
The donors of [Alzheimer's Disease Research], a program of BrightFocus Foundation
Marie Curie FP7 International Outgoing Fellowship - No. 628812
Netherlands Initiative Brain and Cognition (NIHC), a part of the Netherlands Organization for Scientific Research (NWO) - No. 056-13-001
ArticleID:HBM22927
National Institute on Aging grants - No. R01-AG045611; No. P01-AG1792403; No. P50-AG023501; No. R01-AG034570
ark:/67375/WNG-ZQ8L6P41-M
Consortium for Frontotemporal Dementia Research
John Douglas French Alzheimer's Foundation
Alzheimer Nederland and Stichting VUMC funds and Stichting Dioraphte
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1065-9471
1097-0193
DOI:10.1002/hbm.22927